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1. Introduction 
In the foregoing communication [ 1 J evidence has 
been presented which shows that the enzymatic pro- 
perties of actomyosin are influenced by modification 
of SH-groups of myosin. The present communication 
draws attention to the fact that analogous results as 
those obtained by SH-group modification can be 
demonstrated by treating actomyosin with the muscle 
protein cw-actinin. This protein was first described in 
[2-41. It promotes gelation of actin and superpre- 
cipitation of actomyosin and was recently shown to 
activate actomyosin ATPase [5] . Its functional role 
is until now unclear although Ebashi and Ebashi [3 J 
have already mentioned that it may counteract the 
dissociating influence of ATP on actomyosin. The 
common view is now that it is a constituent of the 
Z-line of the myotibril. 
2. Material and methods 
c+actinin (subsequently called actinin) is prepared 
essentially according to [6] (extraction from myo- 
fibrils at low ionic strength, pH 8.5, and subsequent 
precipitation with (NH4)s SO4) and used without 
further purification. The fraction between 0 and 25% 
saturation was used. It contained still denatured ac- 
Abbreviations: 
DTNB : 5,5dithiobis-(-nitrobenzoic acid). 
EGTA : Ethyleneglycol-2-(2+minoethyl)-tetraacetic acid. 
NTP : Nucleoside triphosphate. 
tin; it had no influence on myosin alone. For other 
procedures see [ 1 ] . 
3. Results 
Fig. 1 shows that actinin protects actomyosin in 
quite the same way as does SH-group modification 
against the dissociating influence of ionic strength. 
(This substantiates the statement of [6] that the 
relative activating effect of actinin is more pronounced 
at higher ionic strength.) 
It was recently demonstrated [7] that actinin ac- 
tivates only the ATPase but not the ITPase of acto- 
myosin. The right part of fig. 1 compares the nucleo- 
tide specificity of both activating the actomyosin by 
SH-group modification and by actinin demonstrating 
that in either case only the ATPase is activated. As a 
result, the formerly similar activities of ATPase and 
ITPase become now different. The table corroborates 
the assumption that activation by actinin as well as 
activation by SH-group modification acts via the same 
mechanism. Activation can only be seen if actomyo- 
sin is in a “suboptimal” state. If it is already “elevated” 
as after treatment with actinin, DTNB has no further 
effect: the same activation level is approached by 
both treatments. 
The discussed results show that actinin is able to 
suppress relaxation promoting influences on acto- 
myosin. This is substantiated in fig. 2 in which the 
ATPase activity of artificial actomyosin is plotted 
against the concentration of total Mg. The pattern of 
the control reflects a rather “relaxed” state as can 
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Fig. 1. Modification of NTPase activity of actomyosin by 
DTNB and o-actinin. A: protection of ATPase of artificial 
actomyosin (reconstituted from actin and myosin) against 
the depressive action of ionic strength by a-actinin. - 
control, e----e a-actinin present. B: comparison of ATPase 
and ITPase of artificial actomyosin in the presence and 
absence of modifier. a: modified with DTNB, b: a-actinin 
in the NTPase assay. 100% = 0.45 pmole Pi/mm X mg 
myosin. NTPase assays: KCl: if not otherwise stated 30 
mM; Tris-maleate buffer: 20 mM; pH 7.2; MgCl, : 2 mM for 
ATPase measurements, 10 mM for ITPase measurements, 
ATP: 2 mM; actomyosin: ca. 0.1 mg/ml; a-actinin (if any): 
0.3 mg/ml. (Actin and myosin were premixed before adding 
a-actinin.) DTNB treatment: 60 MM DTNB, 0.6 M KCl, 0.02 
M Tris-HCl buffer, pH 8.0, 20 min, 22”. 
Table 1 
Activation of ATPase of artificial actomyosin by DTNB 
and/or o-actinin. 
ATPase activity (100 = 0.6 ctmole Pilmin x mg myosinl 
Control Actinin DTNB Actinin 
DTNB 
33 100 65 91 
Both kinds of activation produce the same degree of activa- 
tion. 100%: 0.6 pmole Pi/min X mg myosin. 
often be seen in preparations of artificial actomyosin 
(the ATPase activity first declines with increasing 
Mg before reaching a rather low peak). In the pres- 
ence of actinin the picture is that of a “normal” Mg- 
activation: Mg activates the ATPase until an equi- 
molar ratio of Mg and ATP is reached. 
Fig. 2. Dependence of ATPase activity of artificial actomyo 
sin on concentration of total Mg. ATP: 2 mM. 100%: 0.45 
nmole Pi/min X mg myosin. 
4. Discussion 
The fact that actinin can stabilize actomyosin 
ATPase against the dissociating action of ATP seems 
to be not accidental but seems to reflect its physio- 
logical function. This explains why myofibrils which 
naturally contain actinin are less sensitive against 
ionic strength than is artificial actomyosin. Actinin 
is thus an antagonist of the tropomyosin-troponln 
system which in contrast makes actomyosin extreme- 
ly sensitive for the dissociating action of ATP. The 
function of this system is not impaired by actinin. 
This function of actinin further implies that it is 
not only part of the Z-line but must be localized in 
such a way that it can interfere with the actin-myo- 
sin interaction. The nucleotide specificity can be ex- 
plained by the fact that ITP is not so effective in 
dissociating actin and myosin. Accordingly, the 
ITPase of actomyosin is not influenced by the varia- 
tion of ionic strength between p = 0.1 and 0.2 [8,9]. 
Hence, changes in the sensitivity against ionic strength 
will not be reflected by the ITPase. 
It is a matter of further investigation whether ac- 
tinin acts by modifying SH-groups as SH-reagents do 
or if it exerts a more direct influence. 
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